Barely Significant
← all excerpts

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study.

Exp Ther Med · 2026 · PMC13044977 · PMID 41938995

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP<0.0001actually significant
The survival differences between these nomogram-based prognostic groups were highly significant (P<0.0001) ( Fig. 3B , Tables VII and VIII ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.